Cargando…
Peripheral PD-1+CD56+ T-cell frequencies correlate with outcome in stage IV melanoma under PD-1 blockade
Immune checkpoint blockade with anti-PD-1 antibodies is showing great promise for patients with metastatic melanoma and other malignancies, but despite good responses by some patients who achieve partial or complete regression, many others still do not respond. Here, we sought peripheral blood T-cel...
Autores principales: | Bochem, Jonas, Zelba, Henning, Amaral, Teresa, Spreuer, Janine, Soffel, Daniel, Eigentler, Thomas, Wagner, Nikolaus Benjamin, Uslu, Ugur, Terheyden, Patrick, Meier, Friedegund, Garbe, Claus, Pawelec, Graham, Weide, Benjamin, Wistuba-Hamprecht, Kilian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6697319/ https://www.ncbi.nlm.nih.gov/pubmed/31419253 http://dx.doi.org/10.1371/journal.pone.0221301 |
Ejemplares similares
-
Early disappearance of tumor antigen-reactive T cells from peripheral blood correlates with superior clinical outcomes in melanoma under anti-PD-1 therapy
por: Bochem, Jonas, et al.
Publicado: (2021) -
Dynamics of Melanoma-Associated Epitope-Specific CD8+ T Cells in the Blood Correlate With Clinical Outcome Under PD-1 Blockade
por: Gaißler, Andrea, et al.
Publicado: (2022) -
Early decrease of blood myeloid-derived suppressor cells during checkpoint inhibition is a favorable biomarker in metastatic melanoma
por: Gaißler, Andrea, et al.
Publicado: (2023) -
Immune Signatures and Survival of Patients With Metastatic Melanoma, Renal Cancer, and Breast Cancer
por: Wistuba-Hamprecht, Kilian, et al.
Publicado: (2020) -
Monocytic myeloid-derived suppressor cells in advanced melanoma patients: Indirect impact on prognosis through inhibition of tumor-specific T-cell responses?
por: Martens, Alexander, et al.
Publicado: (2014)